Knowledge (XXG)

Verband Forschender Arzneimittelhersteller

Source 📝

233:
For the first time in their 22-year history, vfa companies disclosed how much they paid physicians and other HCW's, medical organizations and medical facilities in June 2016. They sent their data to the "Freiwillige Selbstkontrolle Arzneimittel" (FSA), which publishes aggregate data together with
229:
The vfa claims, that with a manufacturer's share of 50 percent of the retail price, Germany ranks at the bottom in the European comparison. As of 2013 the prescription drug price in Germany consisted of reimbursement to manufacturer (50%), wholesaler (4%), retailing pharmacies (14%) and taxes and
261:
companies with about 80,000 employees, including the following eight largest global pharmaceutical companies with 2014 pharmaceutical sales in brackets: Novartis (51.3B$ ), Pfizer (44.9B$ ), Sanofi (40B$ ), Roche (37.6B$ ), Merck (36.6B$ ), Johnson&Johnson (36.4B$ ),
196:("German Medicines Manufacturers' Association", BAH), has about 450 company members including traditional pharmaceutical manufacturers of OTC drugs and biotechnological products plus about 150 other members with a business interest in healthcare, such as publishers and 234:
other non-vfa companies who adhere to voluntary transparency. They planned to continue once a year, with data available for 3 years. In 2015, 71.000 physicians received 575 Million Euros, and only one third agreed to publication of their name.
266:(33.3B$ ) and GlaxoSmithKline (31.5B$ ). Their 2014 sales have decreased due to corporate mergers and patent expiration, according to the vfa. In 2015, there were 265 pharmaceutical companies per The Federal Statistical Office. 242:
The vfa publishes leading members in their "fotoarchive", with Birgit Fischer as managing director, but no other organizational details like employee figures or operating expenses.
616: 504: 498: 158:
The Verband Forschender Arzneimittelhersteller, or Association of Research-Based Pharmaceutical Companies, was founded in 1994 with headquarters in Berlin as an
730: 725: 186: 720: 735: 203:
The third group is "Pro Generika", founded in 2004 in Berlin. As of 2017 it represents 20 member companies and is the only trade association focusing on
694: 629: 230:
discounts amounting to 32% of the end price, the highest such rate in Europe per vfa, EFPIA and Pharmaceutical associations of European countries.
710: 587: 138:
In Germany more than 18,000 of their employees work in the field of research and development of pharmaceuticals. The vfa's focus has been on
182: 193: 457: 715: 245:
As of July 2017 the vfa's latest statistics are in a 2015 downloadable publication, which contains mostly general PR.
210:
The former "Deutscher Generikaverband" in Berlin, founded in 1986, dissolved in 2012 due to dwindling membership.
135:, representing more than two-thirds of the German pharmaceutical market, with nearly 80,000 employees in Germany. 563: 451: 171: 254: 128: 382: 604: 337: 313: 219: 197: 159: 139: 33: 551: 287: 283: 90: 654: 575: 439: 223: 143: 207:, which cover 77% of the pharmaceutical needs of the Germany's statutory health insurance. 472: 358: 352: 445: 346: 704: 463: 406: 376: 364: 204: 167: 132: 525: 421: 486: 400: 370: 307: 279: 263: 163: 124: 566:
German Medicines Manufacturers' Association, in English, accessed 4 July 2017
641: 415: 394: 388: 301: 292: 258: 655:"Tabelle: Die mächtigsten deutschen Lobbyorganisationen im Überblick" 433: 427: 331: 54: 576:
Verband der Generika- und Biosimilarunternehmen-Grundsätze und Ziele
123:) or Association of Research-Based Pharmaceutical Companies, is the 319: 274: 695:
Euros für Ärzte Datenbank: Wie viel Geld hat mein Arzt bekommen?
93:(BMS), Frank Schöning (Bayer), Hagen Pfundner (Roche) and others 485:
In 2010, the vfa and the BPI were listed as the most powerful
192:
Another pharmaceutical industry association in Germany, the
185:
pharmaceutical companies in Germany are represented by the
147: 617:
Transparenzkodex: Die zweite Veröffentlichungsrunde läuft!
605:"Statistics 2015 - The Pharmaceutical Industry in Germany" 43:
Political advocacy for pharmaceutical companies in Germany
697:
Interactive database, Der Spiegel, 14.07.2016 (German)
693:
Christina Elmer, Patrick Stotz and Stefan Wehrmeyer
683: 505:
Pharmaceutical Research and Manufacturers of America
102: 628:
Christina Elmer, Markus Grill und Stefan Wehrmeyer.
97: 84: 74: 64: 47: 39: 29: 21: 499:Association of the British Pharmaceutical Industry 590:22.11.2012, Deutsche Apotheker Zeitung (German) 17:Verband Forschender Arzneimittelhersteller e.V. 8: 600: 598: 596: 187:Bundesverband der Pharmazeutischen Industrie 16: 489:for the pharmaceutical sector in Germany. 409:named MSD Sharp & Dohme on vfa website 253:As of 2010, the vfa represented 43 German 178:Difference to the other three trade groups 117:Verband Forschender Arzneimittelhersteller 15: 547: 545: 543: 541: 226:on the national and international level. 588:Deutscher Generikaverband wird aufgelöst 564:Bundesverband der Arzneimittelhersteller 194:Bundesverband der Arzneimittelhersteller 517: 218:The vfa's focus has been on lobbying, 7: 731:Pharmaceutical industry trade groups 726:Political advocacy groups in Europe 642:DESTATIS Federal Statistical Office 578:Pro Generika, retrieved 5 July 2017 721:Pharmaceutical industry in Germany 14: 736:Organizations established in 1994 343:C.H. Boehringer Sohn / Ingelheim 295:Pharmaceuticals Deutschland GmbH 711:1994 establishments in Germany 630:Vielen Dank für die Millionen! 1: 298:Aegerion Pharmaceuticals GmbH 752: 632:14 July 2016, Der Spiegel. 452:Swedish Orphan Biovitrum 442:Deutschland Holding GmbH 255:pharmaceutical companies 129:pharmaceutical companies 80:43 drug companies (2017) 661:(in German). 2010-07-19 172:pharmaceutical industry 469:Vifor Deutschland GmbH 162:. It is the German or 644:retrieved 5 July 2017 270:The vfa members are: 198:polling organizations 131:in Germany which are 526:"BPI Mitgliedschaft" 418:PHARMA GmbH Nürnberg 338:Bristol-Myers Squibb 220:political consulting 160:Eingetragener Verein 146:on the national and 140:political consulting 57:, Hausvogteiplatz 13 716:Lobbying in Germany 385:Pharma Holding GmbH 340:GmbH & Co. KGaA 288:Abbott Laboratories 18: 282:Deutschland, 2013 183:Mid to small sized 34:registered society 619:vfa, 20 June 2017 361:GmbH & Co. KG 113: 112: 743: 690: 687: 685: 670: 669: 667: 666: 651: 645: 639: 633: 626: 620: 614: 608: 602: 591: 585: 579: 573: 567: 561: 555: 554:vfa, 5 July 2017 552:member companies 549: 536: 535: 533: 532: 522: 436:Deutschland GmbH 412:Mundipharma GmbH 349:Deutschland GmbH 325:Berlin Chemie AG 316:Deutschland GmbH 224:public relations 144:public relations 109: 106: 104: 19: 751: 750: 746: 745: 744: 742: 741: 740: 701: 700: 682: 679: 674: 673: 664: 662: 659:manager magazin 653: 652: 648: 640: 636: 627: 623: 615: 611: 603: 594: 586: 582: 574: 570: 562: 558: 550: 539: 530: 528: 524: 523: 519: 514: 495: 483: 478: 473:ViiV Healthcare 359:GlaxoSmithKline 353:Eisai (company) 251: 240: 216: 180: 156: 101: 87: 77: 67: 60: 12: 11: 5: 749: 747: 739: 738: 733: 728: 723: 718: 713: 703: 702: 699: 698: 691: 678: 677:External links 675: 672: 671: 646: 634: 621: 609: 592: 580: 568: 556: 537: 516: 515: 513: 510: 509: 508: 502: 494: 491: 482: 479: 477: 476: 470: 467: 461: 455: 449: 446:Sanofi-Aventis 443: 437: 431: 425: 419: 413: 410: 407:Merck & Co 404: 398: 392: 386: 380: 374: 368: 362: 356: 350: 347:Daiichi Sankyo 344: 341: 335: 329: 326: 323: 317: 311: 305: 299: 296: 290: 277: 268: 250: 247: 239: 236: 215: 212: 179: 176: 168:global players 155: 152: 133:global players 111: 110: 99: 95: 94: 88: 85: 82: 81: 78: 75: 72: 71: 68: 65: 62: 61: 59: 58: 51: 49: 45: 44: 41: 37: 36: 31: 27: 26: 23: 13: 10: 9: 6: 4: 3: 2: 748: 737: 734: 732: 729: 727: 724: 722: 719: 717: 714: 712: 709: 708: 706: 696: 692: 689: 681: 680: 676: 660: 656: 650: 647: 643: 638: 635: 631: 625: 622: 618: 613: 610: 606: 601: 599: 597: 593: 589: 584: 581: 577: 572: 569: 565: 560: 557: 553: 548: 546: 544: 542: 538: 527: 521: 518: 511: 506: 503: 500: 497: 496: 492: 490: 488: 481:Controversies 480: 474: 471: 468: 465: 464:UCB (company) 462: 459: 456: 453: 450: 447: 444: 441: 438: 435: 432: 429: 426: 423: 420: 417: 414: 411: 408: 405: 402: 399: 396: 393: 390: 387: 384: 381: 378: 377:Janssen-Cilag 375: 372: 369: 366: 363: 360: 357: 354: 351: 348: 345: 342: 339: 336: 333: 330: 327: 324: 321: 318: 315: 312: 309: 306: 303: 300: 297: 294: 291: 289: 285: 281: 278: 276: 273: 272: 271: 267: 265: 260: 256: 248: 246: 243: 237: 235: 231: 227: 225: 221: 213: 211: 208: 206: 205:generic drugs 201: 199: 195: 190: 188: 184: 177: 175: 173: 169: 165: 161: 153: 151: 149: 145: 141: 136: 134: 130: 126: 122: 118: 108: 100: 96: 92: 89: 83: 79: 73: 69: 63: 56: 53: 52: 50: 46: 42: 38: 35: 32: 28: 24: 20: 663:. Retrieved 658: 649: 637: 624: 612: 583: 571: 559: 529:. Retrieved 520: 487:lobby groups 484: 422:Novo Nordisk 269: 252: 244: 241: 238:Organization 232: 228: 217: 209: 202: 191: 181: 157: 137: 120: 116: 114: 66:Area served 460:Deutschland 448:Deutschland 430:Pharma GmbH 424:Pharma GmbH 373:Pharma GmbH 371:Ipsen Group 328:bioCSL GmbH 308:AstraZeneca 304:Pharma GmbH 280:AbbVie Inc. 264:AstraZeneca 164:trade group 125:trade group 91:Han Steutel 705:Categories 665:2017-06-21 531:2013-11-07 512:References 365:Grünenthal 86:Key people 607:vfa, 28pp 76:Members 493:See also 416:Novartis 395:MediGene 389:Lundbeck 302:Astellas 293:Actelion 284:spin-off 214:Function 150:-level. 70:national 48:Location 259:biotech 249:Members 189:(BPI). 170:in the 154:History 98:Website 22:Founded 458:Takeda 434:Pfizer 428:Otsuka 332:Biogen 314:Baxter 127:of 43 55:Berlin 440:Roche 401:Merck 383:Lilly 320:Bayer 275:Amgen 257:and 40:Focus 686:.vfa 507:(US) 501:(UK) 475:GmbH 466:GmbH 454:GmbH 403:KGaA 391:GmbH 379:GmbH 367:GmbH 355:GmbH 334:GmbH 310:GmbH 222:and 166:for 142:and 115:The 105:.vfa 30:Type 25:1994 688:.de 684:www 286:of 121:vfa 107:.de 103:www 707:: 657:. 595:^ 540:^ 397:AG 322:AG 200:. 174:. 148:EU 668:. 534:. 119:(

Index

registered society
Berlin
Han Steutel
www.vfa.de
trade group
pharmaceutical companies
global players
political consulting
public relations
EU
Eingetragener Verein
trade group
global players
pharmaceutical industry
Mid to small sized
Bundesverband der Pharmazeutischen Industrie
Bundesverband der Arzneimittelhersteller
polling organizations
generic drugs
political consulting
public relations
pharmaceutical companies
biotech
AstraZeneca
Amgen
AbbVie Inc.
spin-off
Abbott Laboratories
Actelion
Astellas

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.